Le Lézard
Classified in: Health, Science and technology
Subject: PLW

NarrativeDx Awarded Patent for Patient Feedback Analysis


AUSTIN, Texas, Nov. 1, 2018 /PRNewswire/ -- NarrativeDx announced today that the US Patent Office has awarded to it a patent that covers the automated analysis of patient feedback, a cornerstone of consumerism strategies for many health systems.

NarrativeDx Patent

U.S Patent Number 10,114,814 covers NarrativeDx's innovative technology that uses natural language processing and machine learning to understand patient feedback from a variety of sources and identify specific opportunities that improve patient satisfaction scores, boost referrals and increase employee engagement.

"This patent recognizes our innovative approach to using artificial intelligence to hear the voice of the patient.  We incorporate all available feedback sources, such as grievance letters, rounding, satisfaction surveys, social media and online physician reviews into a single platform that separates the signal from the noise.  We help our clients turn silos of patient feedback into the right insights that move the needle, in specifically targeted ways for them," said Kyle Robertson, Founder and Chief Executive Officer, NarrativeDx.

This patent is the first in a portfolio of pending applications that cover key aspects of NarrativeDx's innovative technology.  NarrativeDx uses this technology to recognize over 5,400 root causes of patient satisfaction and provide targeted insights that facilitate patient experience and workforce development initiatives.  The technology also incorporates a proprietary understanding of patient experience and language.  "You can't capture the nuance of a patient's experience with sentiment or categories - you need to identify the root cause and what to do about it.  That's why we built the largest, most comprehensive understanding of verbatim patient feedback in existence.  This allows us to be incredibly detailed and accurate where other solutions fail," Robertson added.

According to a 2016 study by Accenture, excellent patient experience increases hospital revenue by 50%. NarrativeDx achieves these outcomes by partnering with healthcare organizations, patient experience and informatics leaders, and consultancies to identify key issues across departments and providers based on patient comments. These actionable insights inform human-centered solutions that improve care experiences, increase revenue, and boost referrals for a thriving healthcare system.

"NarrativeDx has built a one-of-a-kind analytics engine for narrative patient experience data," said Senem Guney, PhD, Founder and Chief Experience Officer, NarrativeDx. "Our company was founded on the simple principle that patient voices matter, and by uncovering important insights from patients' own words about their experiences, we can make meaningful improvements in the delivery of patient-centered care that brings value to the patient-consumer."

Founded in 2014 by AI engineer and IP lawyer, Kyle Robertson, JD, and Senem Guney, PhD, CPXP NarrativeDx has seen steady growth in patient experience and the company continues to invest heavily in product innovation and improving the patient experience.

About NarrativeDx
NarrativeDx, based in Austin, TX, is the artificial intelligence platform for patient experience. We help hospital leaders and care providers hear the voice of their patients. Our natural language processing and machine learning technology provides actionable insights from patient comments to improve their institution's patient experience, drive patient referrals, increase hospital revenue, and boost hospital reputations.

Contact:
William Rodriguez
william@narrativedx.com
+1-512-900-7720

 

(PRNewsfoto/NarrativeDx)

SOURCE NarrativeDx


These press releases may also interest you

at 06:21
Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for sustainability and humanitarianism, today announced the deployment of AI-powered mammography services across Costa Rica to support the...

at 06:18
Surrey FA and Chelsea FC Foundation are proud to announce their collaborative effort once again to offer empowering coaching sessions to female refugees in the local community. These sessions will provide an opportunity for women to engage with...

at 06:05
BeiGene, Ltd. , a global oncology company, today announced that the European Commission (EC) has approved tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications, including first- and second-line use....

at 06:05
Vizient, Inc. hosted its inaugural Insight: Cell, Gene, and Specialty Pharmacy Symposium, bringing together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals along with other stakeholders to discuss...

at 06:05
SprintRay, the leader in dental 3D printing, unveiled the Company's most significant innovation to-date to over 250 dental professionals at 3DNext, their summit in Miami. The Midas Digital Press 3D Printer is poised to not only transform dental...

at 06:00
Panacea Healthcare Solutions,...



News published on and distributed by: